<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to polymyalgia rheumatica - inflammatory condition causing muscle pain and stiffness in older adults.">
    <meta name="keywords" content="polymyalgia rheumatica, PMR, muscle stiffness, inflammatory condition, shoulder hip pain">
    <title>Polymyalgia Rheumatica | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Polymyalgia Rheumatica</h1><p>Inflammatory muscle pain in older adults</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Polymyalgia Rheumatica?</h2>
                <p>Polymyalgia rheumatica (PMR) is an inflammatory condition causing muscle pain and stiffness, primarily in the shoulders and hips. It almost exclusively affects people over 50, with average onset around age 70. It responds dramatically to corticosteroids.<sup>1</sup></p>

                <h2>Symptoms<sup>2</sup></h2>
                <ul>
                    <li>Aching in shoulders and upper arms</li>
                    <li>Aching in hips and thighs</li>
                    <li>Morning stiffness (>45 minutes)</li>
                    <li>Difficulty raising arms</li>
                    <li>Trouble getting up from chair</li>
                    <li>Fatigue</li>
                    <li>Low-grade fever</li>
                    <li>Weight loss</li>
                </ul>

                <h2>Diagnosis</h2>
                <ul>
                    <li>Elevated ESR and/or CRP</li>
                    <li>Clinical presentation</li>
                    <li>Rapid response to prednisone</li>
                    <li>No specific test - diagnosis of exclusion</li>
                    <li>Rule out other conditions</li>
                </ul>

                <h2>Association with Giant Cell Arteritis</h2>
                <ul>
                    <li>15-20% of PMR patients develop GCA</li>
                    <li>Watch for headache, vision changes, jaw pain</li>
                    <li>GCA is a medical emergency</li>
                </ul>

                <h2>Treatment<sup>3</sup></h2>
                <h3>Corticosteroids</h3>
                <ul>
                    <li>Prednisone is first-line treatment</li>
                    <li>Dramatic response within days</li>
                    <li>Slow taper over 1-2 years</li>
                    <li>Many need treatment longer</li>
                </ul>

                <h3>Managing Side Effects</h3>
                <ul>
                    <li>Calcium and vitamin D</li>
                    <li>Bone density monitoring</li>
                    <li>Blood sugar monitoring</li>
                </ul>

                <h2>Prognosis</h2>
                <p>PMR is self-limiting but may last 1-5 years. Most people eventually taper off medication completely.</p>

                <h2>References</h2>
                <ol>
                    <li>Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. <em>Lancet</em>. 2008;372(9634):234-245.</li>
                    <li>Dasgupta B, Cimmino MA, Maradit-Kremers H, et al. 2012 provisional classification criteria for polymyalgia rheumatica. <em>Arthritis Rheum</em>. 2012;64(4):943-954.</li>
                    <li>Dejaco C, Singh YP, Perel P, et al. 2015 recommendations for the management of polymyalgia rheumatica. <em>Arthritis Rheumatol</em>. 2015;67(10):2569-2580.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
